饮食控制和BMI对2型糖尿病患者的梅特福林反应的影响
相关实验视频
Updated: Jun 14, 2025

06:00
Fixation and Operational Method for Abdominal Massage in T2DM Mice
Published on: March 7, 2025
164
Alaa Abd Al-Hussain Naem1, Fadhaa Abdulameer Ghafil1, Mona N Al-Terehi2
1Department of Pharmacology and Clinical Pharmacy, Al-Zahraa University for Women, Karbala, Iraq
概括
身体质量指数 (BMI) 和饮食控制影响2型糖尿病的管理. 较低的BMI和控制的饮食与在甲福明单一治疗的患者中更好的血糖控制相关.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 临床研究 临床研究
背景情况:
- 2型糖尿病 (T2DM) 是一个全球性的健康问题.
- 甲胺是T2DM的第一线治疗方法.
- 个人对甲福明的反应各不相同,因此需要对影响因素进行研究.
研究的目的:
- 研究身体质量指数 (BMI) 和饮食习惯对伊拉克T2DM患者甲胺单疗疗效的影响.
- 根据生活方式因素,识别基于甲福林反应的潜在预测因素.
主要方法:
- 一项涉及150名伊拉克T2DM患者的横截面研究,年龄在30至70岁之间,每天接受1000毫克甲福林单一治疗至少三个月.
- 收集的数据包括BMI,HbA1c,禁食血糖,禁食血清胰岛素,HOMA-IR和胰岛素敏感性.
- 根据HbA1c水平,患者被分为良好 (HbA1c ≤6.5%) 和不良 (HbA1c ≥6.5%) 的响应者.
主要成果:
- 在特定的BMI亚组内或在实践饮食控制的人中,在良好和不良反应者之间没有观察到血糖控制的显著差异.
- 然而,一个趋势表明更好的血糖控制 (降低HbA1c,禁食葡萄糖等). 在BMI较低的患者和那些遵守控制饮食的患者中.
- 这些发现表明,较低的BMI和饮食坚持对于在T2DM患者的血糖管理中具有普遍的益处.
结论:
- 虽然BMI和饮食控制没有显示出对子组内甲福林反应的显著差异性影响,但它们是T2DM整体血糖控制的关键因素.
- 生活方式的修改,包括体重管理和饮食坚持,仍然是优化糖尿病护理的基础.
- 需要进一步的研究,以阐明BMI,饮食和不同人群中甲胺疗效之间的复杂相互作用.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
183
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
183
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Carbohydrate Metabolism
10.9K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.9K
Diabetes: Management and Pharmacotherapy
245
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
245
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Insulin: Dosing Regimen and Adverse Effects
160
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
160

